← back to search
Hans Petter Eikesdal
Haukeland University Hospital · NO
Area of research
Molecular Biology · Genetics
Research interest
Research interests include PI3K/AKT/mTOR signaling in cancer, BRCA gene mutations in cancer, PARP inhibition in cancer therapy, and Angiogenesis and VEGF in Cancer.
h-index
23
citations
1,827
works
97
NIH funding
—
primary concept
Medicine
email
hans.eikesdal@uib.no
Recent publications
PARP-inhibition reprograms macrophages toward an anti-tumor phenotype
Cell Reports
2022
cited by
55
position: middle
doi
Lymphatic vessels regulate immune microenvironments in human and murine melanoma
Journal of Clinical Investigation
2016
cited by
192
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Lin Wang
· Université Bourgogne Franche-Comté
1
papers (2022–2022)
Qi Wang
· Shihezi University
1
papers (2022–2022)
Dan Wang
· People 's Hospital of Jilin Province
1
papers (2022–2022)
—
·
1
papers (2016–2016)
Andrew Cyr
· Northwell Health
1
papers (2022–2022)
Abhishek Thavamani
· Beth Israel Deaconess Medical Center
1
papers (2022–2022)
Yujing J. Heng
· Boston Medical Center
1
papers (2022–2022)
Stefani Spranger
· Ragon Institute of MGH, MIT and Harvard
1
papers (2016–2016)
—
·
1
papers (2016–2016)
Gerburg M. Wulf
· Harvard University
1
papers (2022–2022)
Felipe Batalini
· Mayo Clinic in Arizona
1
papers (2022–2022)
Maria A.S. Broggi
· AstraZeneca (Japan)
1
papers (2016–2016)
Kari Alitalo
· Wihuri Research Institute
1
papers (2016–2016)
—
·
1
papers (2016–2016)
—
·
1
papers (2022–2022)
—
·
1
papers (2022–2022)
—
·
1
papers (2022–2022)
John M. Asara
· Harvard University
1
papers (2022–2022)
Nathalie Y.R. Agar
· Harvard University
1
papers (2022–2022)
—
·
1
papers (2022–2022)